News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website

 

MediGene Applies Evotec OAI`s Leading Technologies for the Identification Of Novel Drugs to Treat Cardiovascular Diseases (PR Newswire)...the drug Etomoxir to treat congestive heart failure is in phase 2, G207 to treat brain cancers successfully completed phase 1 and is preparing for phase 2 trials,......For the development and the marketing of this vaccine as well as one additional tumor vaccine, strategic product alliances with Schering and Aventis Pharma have been concluded....- Mar 28 6:02 AM ET


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010328/lnw007.html


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740